BDXB Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 mai 2023 @ 22:00):

Stats
Dagens volum	2.76M
Gjennomsnittsvolum	449 584
Markedsverdi	13.69B
EPS	$0.526 ( 2023-09-29 )
Last Dividend	$0.750 ( 2023-02-14 )
Next Dividend	$0 ( N/A )
P/E	7.60
ATR14	$0.267 (0.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-16	Goette Roland	Sell	2 233	Common Stock
2024-01-03	Shan David	Sell	44	Common Stock
2017-12-29	Ring Timothy M	Sell	0	Common Stock
2023-01-24	Jones Christopher Ian Montague	Buy	848	Common Stock
2023-12-11	Garrison Michael David	Sell	1 239	Common Stock

INSIDER POWER
62.50
Last 100 transactions
Buy: 250 011 \| Sell: 82 118

Volum Korrelasjon

Lang: -0.15 (neutral)

Kort: -0.69 (moderate negative)

Signal:(30.604) Neutral

Becton, Dickinson and Korrelasjon

10 Mest positive korrelasjoner
AGQ	0.869
SLV	0.857
SIVR	0.856
PSLV	0.853
SO	0.821
TDI	0.817
AEM	0.805

10 Mest negative korrelasjoner
ZSL	-0.852
NM	-0.84
INSW	-0.831
TEX	-0.821
ASC	-0.818
TNP	-0.817
STAR	-0.801

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Becton, Dickinson and Korrelasjon - Valuta/Råvare

0.26
( neutral )

0.04
( neutral )

0.00
( neutral )

0.09
( neutral )

-0.26
( neutral )

-0.35
( neutral )

Becton, Dickinson and Økonomi

Annual	2023
Omsetning:	$19.37B
Bruttogevinst:	$8.17B (42.17 %)
EPS:	$4.97

FY	2023
Omsetning:	$19.37B
Bruttogevinst:	$8.17B (42.17 %)
EPS:	$4.97

FY	2022
Omsetning:	$18.87B
Bruttogevinst:	$8.48B (44.92 %)
EPS:	$5.93

FY	2021
Omsetning:	$20.25B
Bruttogevinst:	$9.43B (46.56 %)
EPS:	$0

Financial Reports:

No articles found.

Becton, Dickinson and Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.750 (N/A)	$0.750 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Becton, Dickinson and Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.43 - good (94.26%) | Divividend Growth Potential Score: 4.09 - Stable (18.12%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.792	2020-08-13
Last Dividend	$0.750	2023-02-14
Next Dividend	$0	N/A
Payout Date	2023-03-01
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$8.29	--
Avg. Dividend % Per Year	2.49%	--
Score	4.63	--
Div. Sustainability Score	9.43
Div.Growth Potential Score	4.09
Div. Directional Score	6.76	--

Next Divdend (Est)
(2024-07-01)

$0.763 Estimate 2.12 %

Dividend Stability

0.17 Bad

Dividend Score

4.63

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$1.542	3.58%
2021	$3.00	5.44%
2022	$3.00	5.65%
2023	$0.750	1.49%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0644	1.500	8.71	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0240	1.200	9.20	10.00	[0 - 0.3]
returnOnEquityTTM	0.0489	1.500	-0.568	-0.852	[0.1 - 1]
payoutRatioTTM	0.882	-1.000	1.178	-1.178	[0 - 1]
currentRatioTTM	1.082	0.800	9.59	7.67	[1 - 3]
quickRatioTTM	0.457	0.800	-2.02	-1.612	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.242	-0.363	[0.2 - 2]
debtRatioTTM	0.308	-1.500	4.86	-7.30	[0 - 0.6]
interestCoverageTTM	8.19	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
freeCashFlowPerShareTTM	9.13	2.00	5.44	10.00	[0 - 20]
debtEquityRatioTTM	0.636	-1.500	7.46	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.414	1.000	6.44	6.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.98	9.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.213	1.000	9.93	9.93	[0.2 - 2]
assetTurnoverTTM	0.373	0.800	-0.847	-0.678	[0.5 - 2]
Total Score				9.43

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	53.48	1.000	4.70	0	[1 - 100]
returnOnEquityTTM	0.0489	2.50	-0.365	-0.852	[0.1 - 1.5]
freeCashFlowPerShareTTM	9.13	2.00	6.96	10.00	[0 - 30]
dividendYielPercentageTTM	1.607	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
payoutRatioTTM	0.882	1.500	1.178	-1.178	[0 - 1]
pegRatioTTM	0.228	1.500	-1.811	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.176	1.000	8.10	0	[0.1 - 0.5]
Total Score				4.09

Becton, Dickinson and

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.